Phase II trial of PBI 4050 in patients with diabetic nephropathies.
Phase of Trial: Phase II
Latest Information Update: 18 Nov 2016
At a glance
- Drugs PBI 4050 (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacokinetics; Proof of concept; Therapeutic Use
- 18 Nov 2016 According to a ProMetic Life Sciences media release, this study is planned to initiate in early next year.
- 17 Nov 2014 New trial record